Arandomized, double-blind, placebo controlled, phase 3 study of the efficacy and safety of pirfenidone in patients with idiopathic fiborsis

Printer-friendly versionSend by emailPDF version

Name

InterMune Incorporated

Anticipated Amount

197 512.00

Activity Type

Clinical Trial

Award Type

Grant

Date

January 1, 2012 to May 30, 2013

Award Number

004975-00001

Sponsor Award Number

-

Award Contacts

Name

Carr,Gordon E

Title

Principal Investigator

Unit

Medicine

UA@Work is produced by University Communications

888 N. Euclid Ave., Ste. 413 (or) 
P.O. Box 210158, Tucson, AZ 85721

T 520.621.1877  F 520.626.4121

Feedback

2018 © The Arizona Board of Regents on behalf of the University of Arizona